Complex secondary chromosome abnormalities in advanced stage anaplastic large cell lymphoma of children and adolescents: a report from CCG-E08

Cancer Genetics and Cytogenetics

Volumn 171, Issue 2, 2006, Pages 89-96

  Lones, Mark A ^a   Heerema, Nyla A ^b   Le Beau, Michelle M ^c   Perkins, Sherrie L ^d   Kadin, Marshall E ^e   Kjeldsberg, Carl R ^d   Sposto, Richard ^f,g   Meadows, Anna ^h   Siegel, Stuart ^f   Buckley, Jonathan ^g   Finlay, Jonathan ^f   Abromowitch, Minnie ⁱ   Cairo, Mitchell S ^j   Sanger, Warren G ^k  

^a ST JOSEPH HOSPITAL   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

^d UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f CHILDREN S HOSPITAL LOS ANGELES   (United States)

^g UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^h CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

ⁱ Childrens Hospital of Omaha   (United States)

^j Och Spine at New York Presbyterian Hospitals   (United States)

^k UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; GENE PRODUCT; HOX PROTEIN; HOX11 PROTEIN; HYBRID PROTEIN; HYDROCORTISONE; MEPREDNISONE; METHOTREXATE; PREDNISONE; PROTEIN; PROTEIN ALK; PROTEIN MCL 1; PROTEIN NPM; PROTEIN TCL 3; TIOGUANINE; UNCLASSIFIED DRUG; VINCRISTINE;

ADOLESCENT; ANAPLASTIC LARGE CELL LYMPHOMA; ARTICLE; AUTOSOME; CANCER GROWTH; CANCER MORTALITY; CANCER RELAPSE; CASE REPORT; CHILD; CHROMOSOME 10Q; CHROMOSOME 1Q; CHROMOSOME 2; CHROMOSOME 5; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME TRANSLOCATION; CLINICAL TRIAL; DISEASE COURSE; FEMALE; FUSION GENE; HUMAN; HUMAN TISSUE; KARYOTYPE; LARGE CELL LYMPHOMA; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; RELAPSE;

ADOLESCENT; CHILD; CHROMOSOME ABERRATIONS; FEMALE; HUMANS; KARYOTYPING; LYMPHOMA, LARGE-CELL; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RETROSPECTIVE STUDIES; TRANSLOCATION, GENETIC;

EID: 33751004996     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2006.04.019     Document Type: Article

References (47)

1. Sandlund J.T., Downing J.R., and Crist W.M. Non-Hodgkin's lymphoma in childhood. N Engl J Med 334 (1996) 1238-1248
2. Meadows A.T., Sposto R., Jenkin R.D.T., Kersey J.H., Chilcote R.R., Siegel S.E., Coccia P.F., Rosenstock J., Pringle K.C., Stolar C.G., Kadin M.E., and Hammond G.D. Similar efficacy of 6 and 18 months of therapy with four drugs (COMP) for localized non-Hodgkin's lymphoma of children: a report from the Children's Cancer Study Group. J Clin Oncol 7 (1989) 92-99
3. Link M.P., Shuster J.J., Donaldson S.S., Berard C.W., and Murphy S.B. Treatment of children and young adults with early-stage non-Hodgkin's lymphoma. N Engl J Med 337 (1997) 1259-1266
4. Brugieres L., Le Deley M.C., Pacquement H., Meguerian-Bedoyan Z., Terrier-Lacombe M.J., Robert A., Pondarre C., Leverger G., Devalck C., Rodary C., Delsol G., and Hartmann O. CD30(+) anaplastic large cell lymphoma in children: analysis of 82 patients enrolled in two consecutive studies of the French Society of Pediatric Oncology. Blood 92 (1998) 3591-3598
5. Seideman K., Tiemann M., Schrappe M., Yakisan E., Simonitsch I., Janka-Schaub G., Dorffel W., Zimmermann M., Mann G., Gadner H., Parwaresch R., Riehm H., and Reiter A. Short pulse B-non-Hodgkin lymphoma-type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: a report of the Berlin-Frankfurt-Munster group trial NHL-BFM 90. Blood 97 (2001) 3699-3706
6. Laver J.H., Mahmoud H., Pick T.E., Hutchison R.E., Weinstein H.J., Schwenn M., Weitzman S., Murphy S.B., Ochoa S., and Shuster J.J. Results of a randomized phase III trial in children and adolescents with advanced stage diffuse large cell non-Hodgkin's lymphoma: a Pediatric Oncology Group study. Leukemia Lymphoma 43 (2002) 105-109
7. Abromowitch M., Sposto R., Perkins S., Hetherington M., Meadows A.T., and Finlay J. Preliminary results of CCG-5941: a pilot study in children and adolescents with anaplastic large cell lymphoma. [Abstract]. Ann Oncol 13 Suppl. 2 (2002) 32
8. Cortes J.E., and Kantarjian H.M. Acute lymphoblastic leukemia: a comprehensive review with emphasis on biology and therapy. Cancer 76 (1995) 2393-2417
9. Uckun F.M., Nachman J.B., Sather H.N., Sensel M.G., Kraft P., Steinherz P.G., Lange B., Hutchinson R., Reaman G.H., Gaynon P.S., and Heerema N.A. Poor treatment outcome of Philadelphia chromosome-positive pediatric acute lymphoblastic leukemia despite intensive chemotherapy. Leuk Lymphoma 33 (1999) 101-106
10. Heerema N.A., Sather H.N., Ge J., Arthur D.C., Hilden J.M., Trigg M.E., and Reaman G.H. Cytogenetic studies of infant acute lymphoblastic leukemia: poor prognosis of infants with t(4;11) - a report of the Children's Cancer Group. Leukemia 13 (1999) 679-686
11. Heerema N.A., Sather H.N., Sensel M.G., Liu-Mares W., Lange B.J., Bostrom B.C., Nachman J.B., Steinherz P.G., Hutchinson R., Gaynon P.S., Arthur D.C., and Uckun F.M. Association of chromosome arm 9p abnormalities with adverse risk in childhood acute lymphoblastic leukemia: a report from the Children's Cancer Group. Blood 94 (1999) 1537-1544
12. Heerema N.A., Nachman J.B., Sather H.N., Sensel M.G., Lee M.K., Hutchinson R., Lange B.J., Steinherz P.G., Bostrom B., Gaynon P.S., and Uckun F.M. Hypodiploidy with less than 45 chromosomes confers adverse risk in childhood acute lymphoblastic leukemia: a report from the Children's Cancer Group. Blood 94 (1999) 4036-4045
13. Raimondi S.C. Current status of cytogenetic research in childhood acute lymphoblastic leukemia. Blood 81 (1993) 2237-2251
14. Rimokh R., Magaud J.P., Berger F., Samarut J., Coiffier B., Germain D., and Mason D.Y. A translocation involving a specific breakpoint (q35) on chromosome 5 is characteristic of anaplastic large cell lymphoma ('Ki-1 lymphoma'). Br J Haematol 71 (1989) 31-36
15. Kaneko Y., Frizzera G., Edamura S., Maseki N., Sakurai M., Komada Y., Sakurai M., Tanaka H., Sasaki M., Suchi T., Kikuta A., Wakasa H., Hojo H., and Mizutani S. A novel translocation, t(2;5)(p23;q35), in childhood phagocytic large T-cell lymphoma mimicking malignant histiocytosis. Blood 73 (1989) 806-813
16. Le Beau M.M., Bitter M.A., Larson R.A., Doane L.A., Ellis E.D., Franklin W.A., Rubin C.M., Kadin M.E., and Vardiman J.W. The t(2;5)(p23;q35): a recurring chromosomal abnormality in Ki-1-positive anaplastic large cell lymphoma. Leukemia 3 (1989) 866-870
17. Rosenwald A., Ott G., Pulford K., Katzenberger T., Kuhl J., Kalla J., Ott M.M., Mason D.Y., and Muller-Hermelink H.K. t(1;2)(q21;p23) and t(2;3)(p23;q21): two novel variant translocations of the t(2;5)(p23;q35) in anaplastic large cell lymphoma. Blood 94 (1999) 362-364
18. Liang X., Meech S.J., Odom L.F., Bitter M.A., Ryder J.W., Hunger S.P., Lovell M.A., Meltesen L., Wei Q., Williams S.A., Hutchinson R.N., and McGavran L. Assessment of t(2;5)(p23;q35) translocation and variants in pediatric ALK+ anaplastic large cell lymphoma. Am J Clin Pathol 121 (2004) 496-506
19. Gordon B.G., Weisenburger D.D., Warkentin P.I., Anderson J., Sanger W.G., Bast M., Gnarra D., Vose J.M., Bierman P.J., Armitage J.O., and Coccia P.F. Peripheral T-cell lymphoma in childhood and adolescence: a clinicopathologic study of 22 patients. Cancer 71 (1993) 257-263
20. Sandlund J.T., Pui C.H., Roberts W.M., Santana V.M., Morris S.W., Berard C.W., Hutchison R.E., Ribeiro R.C., Mahmoud H., Crist W.M., Heim M., and Raimondi S.C. Clinicopathologic features and treatment outcome of children with large-cell lymphoma and the t(2;5)(p23;q35). Blood 84 (1994) 2467-2471
21. Weisenburger D.D., Gordon B.G., Vose J.M., Bast M.A., Chan W.C., Greiner T.C., Anderson J.R., and Sanger W.G. Occurrence of the t(2;5)(p23;q35) in non-Hodgkin's lymphoma. Blood 87 (1996) 3860-3868
22. Buckley J.D., Meadows A.T., Kadin M.E., Le Beau M.M., Siegel S., and Robison L.L. Pesticide exposures in children with non-Hodgkin lymphoma. Cancer 89 (2000) 2315-2321
23. Finlay J.L., Anderson J.R., Cecalupo A.J., Hutchinson R.J., Kadin M.E., Kjeldsberg C.R., Provisor A.J., Woods W.G., and Meadows A.T. Disseminated nonlymphoblastic lymphoma of childhood: a Children's Cancer Group Study, CCG-552. Med Pediatr Oncol 23 (1994) 453-463
24. Anderson J.R., Jenkin R.D.T., Wilson J.F., Kjeldsberg C.R., Sposto R., Chilcote R.R., Coccia P.F., Exelby P.R., Siegel S., Meadows A.T., and Hammond G.D. Long-term follow-up of patients treated with COMP or LSA2L2 therapy for childhood non-Hodgkin's lymphoma: a report of CCG-551 from the Children's Cancer Group. J Clin Oncol 11 (1993) 1024-1032
25. Murphy S.B. Classification, staging, and end results of treatment of childhood non-Hodgkin's lymphomas: dissimilarities from lymphomas in adults. Semin Oncol 7 (1980) 332-339
26. Rappaport H. Tumors of the hematopoietic system. Atlas of Tumor Pathology, Fascicle 8 (1966), United States Armed Forces Institute of Pathology, Washington, DC
27. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: Summary and description of a Working Formulation for Clinical Usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project. Cancer 49 (1982) 2112-2135
28. Lones M.A., Cairo M.S., and Perkins S.L. T-cell-rich large B-cell lymphoma in children and adolescents: a clinicopathologic report from the Children's Cancer Group Study CCG-5961. Cancer 88 (2000) 2378-2386
29. Harris N.L., Jaffe E.S., Stein H., Banks P.M., Chan J.K.C., Cleary M.L., Delsol G., De Wolf-Peeters C., Falini B., Gatter K.C., Grogan T.M., Isaacson P.G., Knowles D.M., Mason D.Y., Muller-Hermelink H.K., Pileri S.A., Piris M.A., Ralfkiaer E., and Warnke R.A. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 84 (1994) 1361-1392
30. Jaffe ES, Harris NL, Stein H, Vardiman JW, editors. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. In: World Health Organization Classification of Tumours. Lyon, France: IARC Press, 2001.
31. In: Harnden D.G., and Klinger H.P. (Eds). ISCN. An international system for human cytogenetic nomenclature (1985), S. Karger, Basel
32. Mitelman F. ISCN 1995. An international system for human cytogenetic nomenclature (1995), S. Karger, Basel
33. Falini B., Pulford K., Pucciarini A., Carbone A., De Wolf-Peeters C., Cordell J., Fizzotti M., Santucci A., Pelicci P.G., Pileri S., Campo E., Ott G., Delsol G., and Mason D.Y. Lymphomas expressing ALK fusion protein(s) other than NPM-ALK. Blood (1999) 3509-3515
34. Armstrong R., Duplantier M.M., Trempat P., Hieblot C., Lamant L., Espinos E., Racaud-Sultan C., Allouche M., Campo E., Delsol G., and Touriol C. Differential effects of X-ALK fusion proteins on proliferation, transformation, and invasion properties of NIH3T3 cells. Oncogene 23 (2004) 6071-6082
35. Zutter M., Hockett R.D., Roberts C.W.M., McGuire E.A., Bloomstone J., Morton C.C., Deaven L.L., Crist W.M., Carroll A.J., and Korsmeyer S.J. The t(10;14)(q24;q11) of T-cell acute lymphoblastic leukemia juxtaposes the delta T-cell receptor with TCL3, a conserved and activated locus at 10q24. Proc Natl Acad Sci U S A 87 (1990) 3161-3165
36. Heerema N.A., Sather H.N., Sensel M.G., Kraft P., Nachman J.B., Steinherz P.G., Lange B.J., Hutchinson R.S., Reaman G.H., Trigg M.E., Arthur D.C., Gaynon P.S., and Uckun F.M. Frequency and clinical significance of cytogenetic abnormalities in pediatric T-lineage acute lymphoblastic leukemia: a report from the Children' Cancer Group. J Clin Oncol 16 (1998) 1270-1278
37. Schneider N.R., Carroll A.J., Shuster J.J., Pullen J., Link M.P., Borowitz M.J., Camitta B.M., Katz J.A., and Amylon M.D. New recurring cytogenetic abnormalities and association of blast cell karyotypes with prognosis in childhood T-cell acute lymphoblastic leukemia: a pediatric oncology group report of 343 cases. Blood 96 (2000) 2543-2549
38. Kees U.R., Heerema N.A., Kumar R., Watt P.M., Baker D.L., La M.K., Uckun F.M., and Sather H.N. Expression of HOX11 in childhood T-lineage acute lymphoblastic leukaemia can occur in the absence of cytogenetic aberration at 10q24: a study from the Children's Cancer Group. Leukemia 17 (2003) 887-893
39. Scarisbrick J.J., Woolford A.J., Russell-Jones R.R., and Whittaker S.J. Loss of heterozygosity on 10q and microsatellite instability in advanced stages of primary cutaneous T-cell lymphoma and possible association with homozygous deletion of PTEN. Blood 95 (2000) 2937-2942
40. Speaks S.L., Sanger W.G., Masih A.S., Harrington D.S., Hess M., and Armitage J.O. Recurrent abnormalities of chromosome bands 10q23∼q25 in non-Hodgkin's lymphoma. Genes Chromosomes Cancer 5 (1992) 239-243
41. Fischer T.C., Gellrich S., Muche J.M., Sherev T., Audring H., Neitzel H., Walden P., Sterry W., and Tonnies H. Genomic aberrations and survival in cutaneous T-cell lymphomas. J Invest Dermatol 122 (2004) 579-586
42. Craig R.W., Jabs E.W., Zhou P., Kozopas K.M., Hawkins A.L., Rochelle J.M., Seldin M.F., and Griffin C.A. Human and mouse chromosomal mapping of the myeloid cell leukemia-1 gene: MCL1 maps to human chromosome 1q21, a region that is frequently altered in preneoplastic and neoplastic disease. Genomics 23 (1994) 457-463
43. Rassidakis G.Z., Lai R., McDonnell T.J., Cabanillas F., Sarris A.H., and Medeiros L.J. Overexpression of Mcl-1 in anaplastic large cell lymphoma cell lines and tumors. Am J Pathol 160 (2002) 2309-2310
44. Rassidakis G.Z., Jones D., Lai R., Ramalingam P., Sarris A.H., McDonnell T.J., and Medeiros L.J. BCL-2 family proteins in peripheral T-cell lymphomas: correlation with tumour apoptosis and proliferation. J Pathol 200 (2003) 240-248
45. Mao X., Orchard G., Lillington D.M., Russell-Jones R., Young B.D., and Whittaker S.J. Amplification and overexpression of JunB is associated with primary cutaneous T-cell lymphomas. Blood 101 (2003) 1513-1519
46. Watanabe M., Sasaki M., Itoh K., Higashihara M., Umezawa K., Kadin M.E., Abraham L.J., Watanabe T., and Horie R. JunB induced by constitutive CD30-extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase signaling activates the CD30 promoter in anaplastic large cell lymphoma and Reed-Sternberg cells of Hodgkin lymphoma. Cancer Res 65 (2005) 7628-7634
47. Rassidakis G.Z., Thomaides A., Atwell C., Ford R., Jones D., Claret F.X., and Medeiros L.J. JunB expression is a common feature of CD30+ lymphomas and lymphomatoid papulosis. Mod Pathol 18 (2005) 1365-1370